Ono Pharmaceutical ADR Representing 1/3rd Ord Shs (OPHLY) – cijena dionice i vijesti

Ono Pharmaceutical Co., Ltd. is one of the largest pharmaceutical companies in Japan. It is headquartered in Chuo-ku, Osaka, Japan, with its major plants in Higashinari-ku, Osaka, and Fujinomiya, Shizuoka., and its central research institute at Minase, Shimamoto-cho, Mishima District, Osaka. Ono Pharmaceutical's roots go back to 1717 when Ichibei Ono started his dealer business of pharmaceuticals in Osaka. His business expanded and changed its name a few times, and became Ono Pharmaceutical Industrial Co., Ltd. in 1948. Ono has been listed in Tokyo Stock Exchange since 1963. Its consolidated earnings in the half year ending in March 2018 were 16 billion Japanese yen. Nivolumab, the cancer drug based on the research of Prof. Dr. Tasuku Honjo of Kyoto University, who received the Nobel Prize later in 2018, is marketed by both Ono Pharmaceutical and Bristol-Myers Squibb. In 2024, Harvard University and Ono Pharmaceutical entered into a joint research and drug development agreement. Under it, promising projects to test therapeutic targets will be selected over 5 years under the guidance of Harvard's Office of Technology Development, and ONO will fund the work. Wikipedia

Ono Pharmaceutical ADR Representing 1/3rd Ord Shs – informacije

Glavni izvršni direktorGyo Sagara | Gyo Sagara

Zaposlenici4,21 tis.

Osnovano1717

SjedišteOsaka, Ōsaka, Japan

Sektor-

Web-lokacijaono-pharma.com

Sve vrijednosti su u valuti JPY	ruj 2025.	pro 2025.	ožu 2026.	lip 2026.
Prihod	129,60 mlr.	139,90 mlr.	118,75 mlr.	116,16 mlr.
Trošak prodane robe	34,96 mlr.	36,68 mlr.	33,06 mlr.	28,68 mlr.
Trošak prihoda	34,96 mlr.	36,68 mlr.	33,06 mlr.	28,68 mlr.
Izdaci za istraživanje i razvoj	34,77 mlr.	33,53 mlr.	42,49 mlr.	32,40 mlr.
Ukupni izdaci za istraživanje i razvoj	-	-	-	-
Izdaci za prodaju, opći i administrativni izdaci	30,08 mlr.	31,73 mlr.	27,70 mlr.	23,90 mlr.
Poslovni rashod	64,56 mlr.	67,00 mlr.	77,09 mlr.	56,83 mlr.
Ukupni poslovni rashodi	99,53 mlr.	103,68 mlr.	110,15 mlr.	85,51 mlr.
Poslovni prihod	30,07 mlr.	36,22 mlr.	8,60 mlr.	30,65 mlr.
Ostali neposlovni prihod	-	-	318,00 mil.	−2,00 mil.
Zarada prije poreza uključujući neuobičajene stavke	29,52 mlr.	37,20 mlr.	3,28 mlr.	31,25 mlr.
Zarada prije poreza isključujući neuobičajene stavke	29,52 mlr.	37,20 mlr.	8,77 mlr.	31,25 mlr.
Izdaci za porez na dohodak	7,17 mlr.	8,31 mlr.	2,24 mlr.	7,09 mlr.
Efektivna porezna stopa	24,30 %	22,35 %	68,23 %	22,68 %
Ostali poslovni rashodi	−291,00 mil.	1,73 mlr.	3,81 mlr.	526,00 mil.
Neto dohodak	22,42 mlr.	28,86 mlr.	818,00 mil.	24,15 mlr.
Neto profitna marža	17,30 %	20,63 %	0,69 %	20,79 %
Zarada po dionici	-	-	-	-
Prihod od kamata i ulaganja	677,00 mil.	1,39 mlr.	195,00 mil.	1,38 mlr.
Izdaci za kamate	−1,23 mlr.	−408,00 mil.	−34,00 mil.	−783,00 mil.
Neto izdaci za kamate	−549,00 mil.	979,00 mil.	161,00 mil.	598,00 mil.
Troškovi amortizacije i otpisa	-	-	3,10 mlr.	-
Dobit prije kamata, poreza i amortizacije	39,39 mlr.	45,82 mlr.	18,21 mlr.	39,63 mlr.
Dobit ili gubitak od prodaje imovine	-	-	2,20 mlr.	-

Finance

Pitajte bilo što